
Sign up to save your podcasts
Or


Two big legal cases concerning the fate of FTX founder Sam Bankman-Fried and the CFPB. We’ve got the latest developments on each. Plus, is Microsoft’s new $9B AI tool worth the hype? And the weight-loss drug boom is having major ripple effects on stocks. We’ll look at one buy and one bail as a result of the craze.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By CNBC3.9
308308 ratings
Two big legal cases concerning the fate of FTX founder Sam Bankman-Fried and the CFPB. We’ve got the latest developments on each. Plus, is Microsoft’s new $9B AI tool worth the hype? And the weight-loss drug boom is having major ripple effects on stocks. We’ll look at one buy and one bail as a result of the craze.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

4,085 Listeners

1,355 Listeners

240 Listeners

154 Listeners

970 Listeners

1,170 Listeners

67 Listeners

154 Listeners

33 Listeners

185 Listeners

45 Listeners

1,302 Listeners

586 Listeners

5 Listeners

556 Listeners

20 Listeners

59 Listeners

1,561 Listeners

213 Listeners

410 Listeners

300 Listeners

119 Listeners

171 Listeners

34 Listeners

10 Listeners

29 Listeners

9 Listeners

16 Listeners

2 Listeners